TILT Holdings (TLLTF) EBITDA Margin (2021 - 2025)
TILT Holdings (TLLTF) reported EBITDA Margin of 46.54% for Q2 2025, up 14287.0% on a YoY basis from N/an in Q2 2024, and up 20.12% quarter-over-quarter from 58.26% in Q1 2025.
TILT Holdings (TLLTF) EBITDA Margin (2021 - 2025) Analysis & Trends
TILT Holdings has reported EBITDA Margin for 5 years, with the latest figure at 46.54% in Q2 2025.
- For the quarter ending Q2 2025, EBITDA Margin rose 14287.0% year-over-year to 46.54%; the trailing twelve-month figure through Jun 2025 stood at 85.19% (down 3018.0% YoY), and the FY2024 full-year result was 86.22%, down 4775.0% from the prior year.
- EBITDA Margin for Q2 2025 stood at 46.54%, up from 58.26% in the prior quarter.
- The five-year high for EBITDA Margin was 2.12% in Q2 2021, with the low at 189.41% in Q2 2024.
- Historically, EBITDA Margin has averaged 58.83% across 5 years, with a median of 46.54% in 2025.
- Annual changes were most pronounced in 2024 — EBITDA Margin tumbled 12128 bps — and 2025, when it surged 14287 bps.
- TILT Holdings' EBITDA Margin stood at 60.04% in 2021, then plunged by 175 bps to 165.0% in 2022, then soared by 65 bps to 58.48% in 2023, then sank by 188 bps to 168.65% in 2024, then soared by 72 bps to 46.54% in 2025.
- The last three EBITDA Margin figures came in at 46.54% (Q2 2025), 58.26% (Q1 2025), and 168.65% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | TILT Holdings | - | - | 1.82 Mn | -46.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -46.54% |
| Mar 31, 2025 | -58.26% |
| Dec 31, 2024 | -168.65% |
| Sep 30, 2024 | -46.90% |
| Jun 30, 2024 | -189.41% |
| Mar 31, 2024 | -25.75% |
| Dec 31, 2023 | -58.48% |
| Sep 30, 2023 | -19.46% |
| Jun 30, 2023 | -68.13% |
| Mar 31, 2023 | -11.52% |
| Dec 31, 2022 | -165.00% |
| Sep 30, 2022 | -38.78% |
| Jun 30, 2022 | -15.00% |
| Mar 31, 2022 | -27.47% |
| Dec 31, 2021 | -60.04% |
| Sep 30, 2021 | -2.87% |
| Jun 30, 2021 | 2.12% |